Literature DB >> 12807721

Human invasive trophoblasts transformed with simian virus 40 provide a new tool to study the role of PPARgamma in cell invasion process.

Laëtitia Pavan1, Anne Tarrade, Axelle Hermouet, Claude Delouis, Mattias Titeux, Michel Vidaud, Patrice Thérond, Daniele Evain-Brion, Thierry Fournier.   

Abstract

Invasive cytotrophoblasts play a key role in the development of human placenta and is therefore essential for subsequent development of the embryo. Human implantation is characterized by a major trophoblastic invasion that offers a unique model of a controlled and oriented tumor-like process. The ligand-activated nuclear receptor peroxisome proliferator-activated receptor gamma (PPARgamma) modulates cell growth and differentiation and might be therefore considered as a tumor suppressor. We have recently reported that PPARgamma, in synergy with its dimerization partner retinoid X receptor (RXR)alpha, controls the invasion of human primary cytotrophoblasts. Because these cells are unable to replicate in culture, we have, in the present study, transformed these primary cells with the simian virus 40 large T antigen for studying the role of PPARgamma in cell invasion process. Our results show that the cell line human invasive proliferative extravillous cytotrophoblast (HIPEC) 65 expressed markers of human invasive primary cytotrophoblast as determined by immunocytochemistry, immunobloting and real-time RT-PCR, and were highly invasive in vitro. We have next studied the role of PPARgamma/RXRalpha heterodimers in cell proliferation and invasion. Our results show that PPARgamma and RXRalpha are co-expressed by HIPEC 65 and that, as commonly observed, activation of PPARgamma/RXRalpha heterodimers with the specific PPARgamma agonist rosiglitazone induced lipid droplet accumulation as revealed by oil red O staining. Treatment with rosiglitazone or with the natural PPARgamma agonist 15-deoxy-delta-(12,14) PGJ2 did not modify cell growth, but interestingly, activation of PPARgamma by this synthetic (rosiglitazone) or natural (15d-PGJ2) ligand markedly inhibited cell invasion in a concentration-dependent manner. Finally, we showed that other potential natural PPARgamma ligand such as oxidized-but not native-low-density lipoprotein inhibited cell invasion. This proliferative and invasive human cytotrophoblast cell line from extravillous origin provides a new tool for studying specifically the role of PPARgamma in the control of cell invasion.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12807721     DOI: 10.1093/carcin/bgg074

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  17 in total

Review 1.  Intrauterine trophoblast migration: A comparative view of humans and rodents.

Authors:  Juneo F Silva; Rogéria Serakides
Journal:  Cell Adh Migr       Date:  2016-01-08       Impact factor: 3.405

Review 2.  Critical growth factors and signalling pathways controlling human trophoblast invasion.

Authors:  Martin Knöfler
Journal:  Int J Dev Biol       Date:  2010       Impact factor: 2.203

3.  Investigation of the possible functions of PACAP in human trophoblast cells.

Authors:  G Horvath; D Reglodi; R Brubel; M Halasz; A Barakonyi; A Tamas; E Fabian; B Opper; G Toth; M Cohen; L Szereday
Journal:  J Mol Neurosci       Date:  2014-05-30       Impact factor: 3.444

4.  Activation of peroxisome proliferator-activated receptor gamma by human cytomegalovirus for de novo replication impairs migration and invasiveness of cytotrophoblasts from early placentas.

Authors:  Benjamin Rauwel; Bernard Mariamé; Hélène Martin; Ronni Nielsen; Sophie Allart; Bernard Pipy; Susanne Mandrup; Marie Dominique Devignes; Danièle Evain-Brion; Thierry Fournier; Christian Davrinche
Journal:  J Virol       Date:  2009-12-30       Impact factor: 5.103

5.  Identification of 14-3-3β gene as a novel miR-152 target using a proteome-based approach.

Authors:  Simon Jasinski-Bergner; Franziska Stehle; Evamaria Gonschorek; Jana Kalich; Kristin Schulz; Stefan Huettelmaier; Juliane Braun; Barbara Seliger
Journal:  J Biol Chem       Date:  2014-09-16       Impact factor: 5.157

6.  Inhibition of oesophageal squamous cell carcinoma progression by in vivo targeting of hyaluronan synthesis.

Authors:  Sören Twarock; Till Freudenberger; Eva Poscher; Guang Dai; Katharina Jannasch; Christian Dullin; Frauke Alves; Klaus Prenzel; Wolfram T Knoefel; Nikolas H Stoecklein; Rashmin C Savani; Bernhard Homey; Jens W Fischer
Journal:  Mol Cancer       Date:  2011-03-23       Impact factor: 27.401

7.  Cytomegalovirus Infection Triggers the Secretion of the PPARγ Agonists 15-Hydroxyeicosatetraenoic Acid (15-HETE) and 13-Hydroxyoctadecadienoic Acid (13-HODE) in Human Cytotrophoblasts and Placental Cultures.

Authors:  Kaoutar Leghmar; Nicolas Cenac; Maude Rolland; Hélène Martin; Benjamin Rauwel; Justine Bertrand-Michel; Pauline Le Faouder; Mélinda Bénard; Charlotte Casper; Christian Davrinche; Thierry Fournier; Stéphane Chavanas
Journal:  PLoS One       Date:  2015-07-14       Impact factor: 3.240

8.  Placenta-specific methylation of the vitamin D 24-hydroxylase gene: implications for feedback autoregulation of active vitamin D levels at the fetomaternal interface.

Authors:  Boris Novakovic; Mandy Sibson; Hong Kiat Ng; Ursula Manuelpillai; Vardhman Rakyan; Thomas Down; Stephan Beck; Thierry Fournier; Danielle Evain-Brion; Eva Dimitriadis; Jeffrey M Craig; Ruth Morley; Richard Saffery
Journal:  J Biol Chem       Date:  2009-02-23       Impact factor: 5.157

9.  DNA methylation-mediated down-regulation of DNA methyltransferase-1 (DNMT1) is coincident with, but not essential for, global hypomethylation in human placenta.

Authors:  Boris Novakovic; Nick C Wong; Mandy Sibson; Hong-Kiat Ng; Ruth Morley; Ursula Manuelpillai; Thomas Down; Vardhman K Rakyan; Stephan Beck; Stefan Hiendleder; Claire T Roberts; Jeffrey M Craig; Richard Saffery
Journal:  J Biol Chem       Date:  2010-01-13       Impact factor: 5.157

10.  PPAR Signaling in Placental Development and Function.

Authors:  Yaacov Barak; Yoel Sadovsky; Tali Shalom-Barak
Journal:  PPAR Res       Date:  2008       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.